Superworth

BioRestorative Therapies price to book ratio BRTX

Market value divided by the book value of the company's net assets, since 2022.

Today, Nov 2, 2026
0.6×
5-year median
0.9×
Against its 5-year history
13th
percentile: 0 is its lowest day, 100 its highest
5-year range
0.5× to 21.2×
Peer median
0.7×

BioRestorative Therapies' price to book ratio is 0.6× as of Nov 2, 2026.

That is below its 5-year median of 0.9×, lower than on 87% of days in the last 5 years.

Over that time it ranged from 0.5× in Mar 2024 to 21.2× in Mar 2026.

The median for 6 healthcare stocks of a similar size is 0.7×.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far0.6×0.6×21.2×
20254.5×1.0×5.3×
20241.1×0.5×1.2×
20230.6×0.6×1.8×
20220.6×0.5×1.0×

Against its peers

Companies in Healthcare nearest BioRestorative Therapies' size, closest first, today.

CompanyPrice to book ratio
BRTXBioRestorative Therapies0.6×
OXBROXBRIDGE RE HOLDINGS1.0×
EDUCEducational Development0.2×
GTIMGood Times Restaurants0.4×
MDRRMedalist Diversified0.7×
VIPVulcan Infrastructure & Powern/m
BCGBinah Capital0.9×
Peer median0.7×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on BioRestorative Therapies

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.